1. Home
  2. PTCT vs PJT Comparison

PTCT vs PJT Comparison

Compare PTCT & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$63.29

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo PJT Partners Inc.

PJT

PJT Partners Inc.

HOLD

Current Price

$150.50

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
PJT
Founded
1998
2014
Country
United States
United States
Employees
991
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.4B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
PTCT
PJT
Price
$63.29
$150.50
Analyst Decision
Buy
Buy
Analyst Count
17
4
Target Price
$80.65
★ $178.50
AVG Volume (30 Days)
★ 918.2K
319.3K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
★ 0.66%
EPS Growth
★ 264.48
N/A
EPS
★ 0.90
N/A
Revenue
$264,734,000.00
★ $1,713,671,000.00
Revenue This Year
N/A
$11.12
Revenue Next Year
$17.70
$9.98
P/E Ratio
$69.20
★ $23.03
Revenue Growth
★ 36.19
14.77
52 Week Low
$58.90
$127.73
52 Week High
$90.87
$195.62

Technical Indicators

Market Signals
Indicator
PTCT
PJT
Relative Strength Index (RSI) 34.72 31.10
Support Level N/A $144.58
Resistance Level $68.93 $163.37
Average True Range (ATR) 1.97 5.24
MACD -0.32 -1.89
Stochastic Oscillator 22.43 15.37

Price Performance

Historical Comparison
PTCT
PJT

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services, and others. Geographically, it generates maximum revenue from the United States, followed by the United Kingdom and other markets.

Share on Social Networks: